What ChondroFiller does inside the hip joint

ChondroFiller is a ready-to-use Type I collagen hydrogel — CE-marked, acellular, and free of living cells — designed to be injected directly into the hip joint as an outpatient under ultrasound guidance, with no biopsy, no cell harvesting, and no theatre admission required.

Once inside the joint, the collagen solution gels in situ within three to five minutes at body temperature, moulding to the degenerated articular surface and forming a dimensionally stable scaffold. That scaffold then supports the body's own repair processes through acellular matrix-induced chondrogenesis: progenitor cells from the surrounding synovium and subchondral bone migrate into the matrix and begin laying down new tissue. The product is indicated for diffuse Kellgren-Lawrence Grade III/IV hip osteoarthritis and for focal ICRS Grade III–IV defects up to 6 cm²; it is not a pain-relief injection and contains no hyaluronic acid or anti-inflammatory agents.

Earlier iterations of the product were implanted arthroscopically — a surgical route suited to large, well-bordered focal defects. The current injection pathway is a different proposition entirely: the collagen is delivered through a single needle via a two-chamber syringe, so the appointment takes place in a clinic room rather than an operating theatre, and most patients are on their feet and heading home within the hour.

How to prepare for the day

Preparation for a ChondroFiller hip injection appointment at Lincolnshire Hip — whether in Grantham or Sleaford — is straightforward. There is no surgical pre-operative work-up: no fasting, no pre-operative blood tests, and no general anaesthetic preparation of any kind.

A few practical points to have in order before the day:

• Clothing. Wear loose, comfortable trousers or shorts that allow easy access to the hip without needing to undress fully.
• Transport. Arrange a driver or lift home. Driving immediately after the injection is inadvisable; the hip may feel stiff or slightly swollen, and the local anaesthetic used during the procedure can temporarily affect comfort and control.
• Time. Allow approximately 30–45 minutes in total, covering check-in, the injection itself (typically 15–30 minutes), and a short post-injection observation period of around 20–30 minutes before discharge.
• No additional procedures beforehand. Because ChondroFiller is acellular, there is no harvesting or laboratory stage — the product arrives ready to use.

Inside the procedure room: step by step

The appointment takes place in a standard clinic room. Once comfortable on the treatment couch — lying on your back with the hip area exposed — the clinician cleans the overlying skin with a sterile antiseptic solution. A thin layer of ultrasound gel is then applied, and the probe is placed against the skin.

Live imaging at this point is purposeful rather than precautionary: the clinician uses the real-time picture to map the joint precisely — confirming the femoral head, joint space, and the specific target zone — before a single needle is placed. The imaging continues throughout, so the needle's path is tracked from skin surface to the hip joint itself.

A local anaesthetic is introduced first, numbing the skin and soft tissue along the planned needle track. Most patients describe this stage as a brief sting followed by a dull pressure rather than sharp pain. Once the area is numb, the delivery needle advances under live ultrasound guidance into the hip joint space. When the tip is confirmed in the correct position, the collagen is delivered. The fluid gels in situ within a few minutes — patients occasionally notice a sensation of fullness or pressure as the joint fills, though this passes quickly.

When the needle is withdrawn, there is no incision to close and no wound to dress. A small piece of gauze or tape over the puncture site is typically all that is needed. The procedural part of the appointment is done.

The first 30 minutes after injection

Once the needle is withdrawn and the puncture site covered, the clinical part of the appointment is finished — but patients stay in the room for roughly 20 to 30 minutes before leaving. This is routine observation, not a sign of concern: it allows the collagen matrix to complete its in-situ gelation against the hip joint surfaces and gives the clinic team a quiet window to confirm the patient is comfortable and oriented before discharge.

The most important thing to understand during this period is that ChondroFiller is a structural scaffold, not an analgesic. It does not release pain-relieving agents, and the hip will not feel measurably different on the way out compared with on the way in. Some patients notice a faint sensation of fullness or a low-level pressure in the joint — a consequence of the gel occupying space — but this typically fades quickly. Expecting to walk out pain-free sets an unrealistic benchmark; expecting to walk out no worse than you arrived is realistic and, for most patients, accurate.

Discharge is same-day and straightforward. Gentle, flat-surface walking to the car is entirely appropriate; the arranged driver home takes over from there.

The first 48–72 hours at home

Swelling, a dull ache, and some stiffness in the treated hip over the first two to three days are all expected — they are the joint's natural response to the injection, not a sign that anything has gone wrong. The collagen scaffold is beginning to integrate with the articular surface, and a mild inflammatory reaction is part of that process. These symptoms typically settle within a few days without any specific intervention.

For discomfort, paracetamol at standard doses is generally appropriate. An ice pack wrapped in a cloth — never applied directly to skin — placed over the hip for 10 to 15 minutes a few times a day can help manage localised swelling. Avoid non-steroidal anti-inflammatory drugs (NSAIDs) unless your clinician has specifically cleared them, as reducing inflammation too aggressively in the early days may interfere with the scaffold's integration.

Avoid high-impact loading — running, jumping, or heavy stair-climbing — for at least the first 48 hours. Beyond that, partial weight-bearing with crutches is the standard protective instruction for roughly six weeks. Think of the crutches as a way of protecting the gel while it sets and bonds: the collagen matrix needs time to stabilise before the joint carries full load.

When to contact the clinic

Most early discomfort is self-limiting and falls well within normal range. Contact the Lincolnshire Hip team if you notice rapidly worsening swelling, significant redness or warmth spreading beyond the injection site, a fever, or pain that is severe and worsening rather than gradually easing after 72 hours. These would warrant prompt clinical review.

What recovery looks like over the following months

Recovery from a ChondroFiller hip injection unfolds in stages across several months, and understanding the sequence helps set sensible expectations.

For the first six weeks, the priority is protecting the newly set collagen matrix while it integrates with the surrounding articular surface — hence the crutch-assisted partial weight-bearing described in the preceding days. Active range-of-motion work typically begins around week six, once early scaffold integration is under way; this is usually introduced gradually under physiotherapy guidance rather than all at once.

Return to low-impact activity — swimming, cycling, and sustained walking — is generally expected somewhere between three and six months, depending on how the hip responds and how consistently the loading restrictions have been observed. High-impact activity takes longer and is discussed individually at follow-up.

Published hip-specific evidence offers a useful benchmark. In the Mazek cohort (Journal of Hip Preservation Surgery, 2021), 17 of 21 evaluable patients — 81% — achieved good or excellent cartilage outcomes at three to five years. The broader figure of 70–85% meaningful symptom relief is consistent with this, though it applies most reliably to patients under 50 with isolated focal defects in a well-aligned joint; outcomes outside that profile are less well characterised.

Outcome data for the injection delivery route specifically continue to mature: longer-term follow-up beyond two years is encouraging but still accumulating. The three-month mark is the first practical checkpoint — by then, most patients have a clearer sense of how the hip is responding, and any decision about next steps becomes more grounded in the body's actual trajectory rather than in early post-injection noise.

Lincolnshire Hip is part of the MSK Doctors group and accepts patients without referral for hip assessment.